Beyond Benchmarks 2024
Emergence - Beyond Benchmarks 2024.pdf
Emergence: Top Quartile Startups Are Growing 58% at $10m in ARR | SaaStr
Key takeaway
- For entrepreneurs: Despite challenging growth headwinds and a tough fundraising environment, generational companies are being founded and built right now, with GenAI integration becoming crucial for staying competitive.
- For investors: While overall venture activity has declined, GenAI companies are attracting significant premiums in valuations and round sizes, indicating a shift in investment focus.
Summary
The "Beyond Benchmarks 2024" report by Emergence provides a comprehensive overview of the current enterprise cloud market, focusing on GenAI trends, fundraising environment, and company performance metrics. Based on data from over 600 B2B software companies, the report highlights the significant impact of GenAI on product development, pricing models, and R&D investments. It also reveals a challenging fundraising landscape, with decreased venture activity across all stages, except for GenAI companies. The report emphasizes the importance of efficient growth, customer retention, and strategic adaptation to market conditions for startups navigating this complex environment.
Insights
- 60% of companies leveraged GenAI in a 2023 product release
- Companies building GenAI features invested $2M more in R&D on average
- Native GenAI companies received 80% larger Series A and 260% larger Series B investments
- US software venture activity has continued to decline since the peak in 2021
- ARR growth rates decreased significantly in 2023, with growth stage companies impacted the most
- Net Dollar Retention (NDR) decreased by 15 percentage points compared to previous years
- Products with $10-100K Annual Contract Value (ACV) had the lowest Gross Dollar Retention
- CAC Payback is highest as companies start scaling
- Burn multiples decrease with scale, but increased overall in 2023
- 79% of companies did not change their pricing in 2023
Implications